World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
90
Citations
25951
World Ranking
1086
National Ranking
584

Medicine

D-Index
90
Citations
25946
World Ranking
12335
National Ranking
6316

Overview

Victor H. Engelhard is a researcher affiliated with the University of Virginia in the United States. Their work primarily focuses on the fields of Immunology and Microbiology, with significant contributions to Medicine. The subfields in which they have published include Immunology, Oncology, Molecular Biology, Biomedical Engineering, and Immunology and Allergy.

The main research topics covered by Victor H. Engelhard revolve around Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, and T-cell and B-cell Immunology. Additional topics include vaccines and immunoinformatics approaches, CAR-T cell therapy research, and Cell Adhesion Molecules Research.

The scholar has published in several scientific venues multiple times. Frequent publication venues include Cancer Immunology Research, The Journal of Immunology, Journal for ImmunoTherapy of Cancer, Cancer Cell, and Cell Reports.

Recent notable papers authored or co-authored by Victor H. Engelhard include:

  • Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts, 2021, Cell Reports
  • B cells and cancer, 2021, Cancer Cell
  • Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma, 2021, Journal for ImmunoTherapy of Cancer
  • Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy, 2020, Cancer Immunology Research
  • MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma, 2020, Journal for ImmunoTherapy of Cancer

Victor H. Engelhard frequently collaborates with other researchers. Among their most common co-authors are Craig L. Slingluff, Anthony B. Rodriguez, Robin S. Lindsay, Marit M. Melssen, and Ileana S. Mauldin.

Best Publications

  • Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

    Donald F. Hunt;Robert A. Henderson;Jeffrey Shabanowitz;Kazuyasu Sakaguchi

  • Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines

    Andrea L. Cox;Jonathan Skipper;Ye Chen;Robert A. Henderson

  • HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation.

    Robert A. Henderson;Hanspeter Michel;Kazuyasu Sakaguchi;Jeffrey Shabanowitz

  • Cell-cell adhesion mediated by CD8 and MHC class I molecules.

    Anne M. Norment;Russell D. Salter;Peter Parham;Victor H. Engelhard

  • Structure of Peptides Associated with Class I and Class II MHC Molecules

    Victor H. Engelhard

  • The minor histocompatibility antigen HA-1 : A diallelic gene with a single amino acid polymorphism

    J.M.M. den Haan;L.M. Meadows;W. Wang;J. Pool

  • Identification of a Graft-versus-Host Disease-associated human minor Histocompatibility antigen.

    Joke M. M. den Haan;Nicholas E. Sherman;Els Blokland;Eric Huczko

  • An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.

    J C Skipper;R C Hendrickson;P H Gulden;V Brichard

  • The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

    Alex Yee-Chen Huang;Pamela H. Gulden;Amina S. Woods;Matthew C. Thomas

  • Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

    Craig L. Slingluff;Gina R. Petroni;Galina V. Yamshchikov;Donna L. Barnd

  • Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation

    Jarish N. Cohen;Cynthia J. Guidi;Eric F. Tewalt;Hui Qiao

  • The HLA-A^*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

    Leslie Meadows;Wei Wang;Joke M.M den Haan;Els Blokland

  • NKT Cell Activation Mediates Neutrophil IFN-γ Production and Renal Ischemia-Reperfusion Injury

    Li Li;Liping Huang;Sun-sang J. Sung;Peter I. Lobo

  • Structure of peptides associated with MHC class I molecules

    Victor H. Engelhard

  • Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation

    Courtney M. Lappas;Yuan-Ji Day;Melissa A. Marshall;Victor H. Engelhard

  • Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor Control

    David W. Mullins;Stacey L. Sheasley;Rebecca M. Ream;Timothy N.J. Bullock

  • Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.

    Craig L. Slingluff;Galina Yamshchikov;Patrice Neese;Holly Galavotti

  • Sphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720

    Yugesh Kharel;Sangderk Lee;Ashley H. Snyder;Stacey L. Sheasley-O'Neill

  • Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

    Elizabeth D. Thompson;Hilda L. Enriquez;Yang Xin Fu;Victor H. Engelhard

  • Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

    Eric F. Tewalt;Jarish N. Cohen;Sherin J. Rouhani;Cynthia J. Guidi

Frequent Co-Authors

Donald F. Hunt
Donald F. Hunt University of Virginia
Jeffrey Shabanowitz
Jeffrey Shabanowitz University of Virginia
Craig L. Slingluff
Craig L. Slingluff University of Virginia
Els Goulmy
Els Goulmy Leiden University Medical Center
Andrea L. Cox
Andrea L. Cox Johns Hopkins University School of Medicine
Peter Parham
Peter Parham Stanford University
Stanley R. Riddell
Stanley R. Riddell University of Washington
Edus H. Warren
Edus H. Warren Fred Hutchinson Cancer Research Center
Jarrod A. Marto
Jarrod A. Marto Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with related healthcare fields, particularly nursing. For those already in nursing, transitioning into specialized roles such as acute care is possible through programs like the fnp to acnp bridge program online. This pathway offers a flexible way to advance clinical expertise without disrupting professional commitments.

For individuals seeking a quicker entry into advanced nursing roles, an accelerated np program provides an efficient route. These programs condense the curriculum to prepare students rapidly for nurse practitioner positions, ideal for those eager to accelerate their career growth.

Beginners with no nursing background can benefit from online rn programs for non nurses, which allow direct entry into nursing through flexible online coursework. These programs minimize barriers to entry and broaden access to nursing careers.

Lastly, considering the application process and ease of admission, many opt for easiest absn programs to get into. These accelerated programs provide a practical pathway for obtaining a Bachelor of Science in Nursing (BSN) with fewer entry hurdles, ideal for fast-tracking into healthcare jobs related to immunology.

Best Scientists Citing Victor H. Engelhard

Trending Scientists

Recently Published Articles